ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Clinical Research Network in Non-Alcoholic Steatohepatitis - Adult Trial

This study is not yet open for patient recruitment.

Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this study is to determine if therapy with pioglitazone or vitamin E will lead to an improvement in liver histology in non-diabetic adult patients with NASH.

Condition Treatment or Intervention Phase
Liver Diseases
 Drug: Pioglitazone
 Drug: Vitamin E
 Drug: Placebo
Phase III

MedlinePlus related topics:  Liver Diseases

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria


Location Information


California
      University of California, San Diego, San Diego,  California,  92103,  United States

      University of California, San Francisco, San Francisco,  California,  94143,  United States

Indiana
      Indiana University, Indianapolis,  Indiana,  46202,  United States

Maryland
      Johns Hopkins University, Baltimore,  Maryland,  21205,  United States

Missouri
      St. Louis University, St. Louis,  Missouri,  63110,  United States

Ohio
      Case Western Reserve University, Cleveland,  Ohio,  44109,  United States

Virginia
      Virginia Commonwealth University, Richmond,  Virginia,  23298,  United States

Washington
      University of Washington, Seattle,  Washington,  98195,  United States

More Information

National Institute of Diabetes and Digestive and Kidney Diseases

Study ID Numbers:  NASH - ADULT
Record last reviewed:  July 2004
Record first received:  July 1, 2003
ClinicalTrials.gov Identifier:  NCT00063622
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2004-10-20
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act